How It Works
Our Science
Learn
Reviews
Lymphoma 101
Find a Hospital
Blog
Content Library
Veterinarians
For Veterinarians
Vet Portal
Feline Lymphoma Research
About
Get Started
Find a Vet
Get Started
Press
ImpriMed
in the news
For press opportunities, please email
press@imprimedicine.com.
In the News
October 10, 2022
The latest and greatest in canine oncology treatment
Read More
August 11, 2022
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More
May 26, 2022
Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 3)
Read More
May 25, 2022
Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 2)
Read More
May 24, 2022
Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 1)
Read More
April 23, 2022
Novel veterinary oncologic treatments and diagnostics
Read More
February 15, 2022
AI’s Computing Power Could Make Fusion Energy Practical
Read More
December 26, 2021
Don't Guess Your Pet's Condition, Treat It with ImpriMed
Read More
September 23, 2021
Interview with ImpriMed CEO & Co-Founder Sungwon Lim
Read More
May 30, 2021
This Test Might Make All The Difference When Fighting Lymphoma
Read More
April 6, 2021
ImpriMed: Fighting Cancer — From Dogs To Humans
Read More
September 4, 2017
At Pear demo day, a who’s who of VCs, and plenty of fresh ideas
Read More
Video & Podcast Interviews
January 13, 2022
Personalized Medicine in Veterinary Oncology
Veterinary Innovation Podcast
Watch or Listen Now→
August 10, 2021
Interview with Dr. Sungwon Lim, CEO of ImpriMed
Innovating with Scott Amyx
Watch or Listen Now→
July 13, 2021
Tech Founder Interview with Sungwon Lim, CEO & Founder of ImpriMed
Tech Founder Show by Insivia
Watch or Listen Now→
November 12, 2020
Which Drugs Can Kill Your Dog's Cancer Cells? - ImpriMed's Sungwon Lim | Canine Cancer Rebel
Canine Cancer Alliance
Watch or Listen Now→
November 28, 2019
Interview with Sungwon Lim: Founder & CEO of ImpriMed
Entrepreneurship, Interviews, Level Up!
Watch or Listen Now→
Press Releases
October 5, 2022
ImpriMed Wins Place at the Mayo Clinic Platform_Accelerate Immersive Program
Read More →
June 13, 2022
40 Under 40 in Cancer Class of 2022 Recognizes Dr. Sungwon Lim, ImpriMed CEO & Co-Founder
Read More →
May 2, 2022
ImpriMed Presents New Research Findings at The Veterinary Cancer Society (VCS) Mid-Year Conference
Read More →
March 21, 2022
ImpriMed AI and machine learning is disrupting the veterinary oncology tools available for better treatment outcomes
Read More →
February 16, 2022
ImpriMed Publishes Exclusive Canine Patients Data Analysis
Read More →
February 1, 2022
ImpriMed CEO and Co-founder Dr. Sungwon Lim Wins Prestigious “Top Industry Leader” Award from Life Sciences Voice
Read More →
January 24, 2022
ImpriMed Reports Significant Growth in 2021 with Pre-Series A Funding, New Product Launches, and Team Expansion
Read More →
October 19, 2021
ImpriMed Launches New Diagnostic Services for Canine Lymphoma
Read More →
July 12, 2021
ImpriMed Initiates Feline Lymphoma Drug Response Prediction Study
Read More →
May 24, 2021
ImpriMed Launches Chemo Response Prediction and Immunophenotyping Services for Canine Lymphoma
Read More →
April 13, 2021
ImpriMed Raises $8M to Commercialize AI-Driven Personalized Drug Response Prediction Service in Pet Cancer Market
Read More →
February 2, 2021
ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers
Read More →
April 12, 2019
ImpriMed Raises $4M for Customized Cancer Treatments for Dogs
Read More →
